Pulmonx Corporation (LUNG) Tops Q3 EPS by 4c

Pulmonx Corporation (NASDAQ: LUNG) reported Q3 EPS of ($0.39), $0.04 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $17.7 million versus the consensus estimate of $16.39 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Chip stocks hit record 19.7% of S&P 500, quadrupling since 2020
• Phinia to acquire stoba Group in deal expected to close in Q4 2026